The Dual Orexin/Hypocretin Receptor Antagonist, Almorexant, in the Ventral Tegmental Area Attenuates Ethanol Self-Administration

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Srinivasan, Subhashini ^a   Simms, Jeffrey A ^a   Nielsen, Carsten K ^a   Lieske, Steven P ^a,f   Bito Onon, Jade J ^a   Yi, Henry ^a   Hopf, Frederic Woodward ^a   Bonci, Antonello ^c,d,e   Bartlett, Selena E ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALMOREXANT; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; SUCROSE;

ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CONTROL; BRAIN ELECTROPHYSIOLOGY; BRAIN REGION; CELLULAR PARAMETERS; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG INFUSION; DRUG SELF ADMINISTRATION; EXTRACELLULAR RECORDING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INSTRUMENTAL CONDITIONING; LOCOMOTION; MALE; NONHUMAN; RAT; SUBSTANTIA NIGRA; SUGAR INTAKE; VENTRAL TEGMENTUM;

ACETAMIDES; ANIMALS; ELECTROPHYSIOLOGY; ETHANOL; ISOQUINOLINES; MALE; MOTOR ACTIVITY; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; SUCROSE; VENTRAL TEGMENTAL AREA;

ANIMALIA;

EID: 84866678830     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044726     Document Type: Article

References (60)

1. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, et al. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95: 322-327.
2. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585.
3. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437-451.
4. Lin L, Faraco J, Li R, Kadotani H, Rogers W, et al. (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98: 365-376.
5. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, et al. (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18: 9996-10015.
6. Fadel J, Deutch AY, (2002) Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111: 379-387.
7. Haynes AC, Jackson B, Chapman H, Tadayyon M, Johns A, et al. (2000) A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul Pept 96: 45-51.
8. Yamada H, Okumura T, Motomura W, Kobayashi Y, Kohgo Y, (2000) Inhibition of food intake by central injection of anti-orexin antibody in fasted rats. Biochem Biophys Res Commun 267: 527-531.
9. Shirasaka T, Nakazato M, Matsukura S, Takasaki M, Kannan H, (1999) Sympathetic and cardiovascular actions of orexins in conscious rats. Am J Physiol 277: R1780-1785.
10. Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, et al. (2003) Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23: 3106-3111.
11. Narita M, Nagumo Y, Hashimoto S, Narita M, Khotib J, et al. (2006) Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 26: 398-405.
12. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A, (2006) Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49: 589-601.
13. Dayas CV, McGranahan TM, Martin-Fardon R, Weiss F, (2008) Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biol Psychiatry 63: 152-157.
14. Richards JK, Simms JA, Steensland P, Taha SA, Borgland SL, et al. (2008) Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 199: 109-117.
15. Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B, (2006) The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 148: 752-759.
16. Jupp B, Krivdic B, Krstew E, Lawrence AJ, (2011) The orexin receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats. Brain Res 1391: 54-59.
17. Moorman DE, Aston-Jones G, (2009) Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol-preferring Sprague-Dawley rats. Alcohol 43: 379-386.
18. Shoblock JR, Welty N, Aluisio L, Fraser I, Motley ST, et al. (2011) Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psychopharmacology (Berl) 215: 191-203.
19. Heilig M, Egli M, (2006) Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther 111: 855-876.
20. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, et al. (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. Jama 295: 2003-2017.
21. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP, (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49: 876-880.
22. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, et al. (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28: 1546-1552.
23. Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA, (2001) Naltrexone in the treatment of alcohol dependence. N Engl J Med 345: 1734-1739.
24. Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, et al. (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 65: 135-144.
25. Neubauer DN, (2010) Almorexant, a dual orexin receptor antagonist for the treatment of insomnia. Curr Opin Investig Drugs 11: 101-110.
26. Simms JA, Bito-Onon JJ, Chatterjee S, Bartlett SE, (2010) Long-Evans rats acquire operant self-administration of 20% ethanol without sucrose fading. Neuropsychopharmacology 35: 1453-1463.
27. Paxinos G, and Watson C. (1997) The Rat Brain in Stereotaxic Coordinates: Academic Press, San Diego, CA.
28. Simms JA, Haass-Koffler CL, Bito-Onon J, Li R, Bartlett SE, (2012) Mifepristone in the central nucleus of the amygdala reduces yohimbine stress-induced reinstatement of ethanol-seeking. Neuropsychopharmacology 37: 906-918.
29. Margolis EB, Mitchell JM, Ishikawa J, Hjelmstad GO, Fields HL, (2008) Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition. J Neurosci 28: 8908-8913.
30. Wanat MJ, Hopf FW, Stuber GD, Phillips PE, Bonci A, (2008) Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J Physiol 586: 2157-2170.
31. Madhavan A, Bonci A, Whistler JL, (2010) Opioid-Induced GABA potentiation after chronic morphine attenuates the rewarding effects of opioids in the ventral tegmental area. J Neurosci 30: 14029-14035.
32. Bonci A, Malenka RC, (1999) Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area. J Neurosci 19: 3723-3730.
33. Malherbe P, Borroni E, Pinard E, Wettstein JG, Knoflach F, (2009) Biochemical and electrophysiological characterization of almorexant, a dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist: comparison with selective OX1 and OX2 antagonists. Mol Pharmacol 76: 618-631.
34. Steiner MA, Lecourt H, Strasser DS, Brisbare-Roch C, Jenck F, (2011) Differential effects of the dual orexin receptor antagonist almorexant and the GABA(A)-alpha1 receptor modulator zolpidem, alone or combined with ethanol, on motor performance in the rat. Neuropsychopharmacology 36: 848-856.
35. Brisbare-Roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, et al. (2007) Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 13: 150-155.
36. Samson HH, Tolliver GA, Haraguchi M, Hodge CW, (1992) Alcohol self-administration: role of mesolimbic dopamine. Ann N Y Acad Sci 654: 242-253.
37. Samson HH, Hodge CW, (1993) The role of the mesoaccumbens dopamine system in ethanol reinforcement: studies using the techniques of microinjection and voltammetry. Alcohol Alcohol Suppl 2: 469-474.
38. Gonzales RA, Job MO, Doyon WM, (2004) The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement. Pharmacol Ther 103: 121-146.
39. Stuber GD, Hopf FW, Tye KM, Chen BT, Bonci A, (2010) Neuroplastic alterations in the limbic system following cocaine or alcohol exposure. Curr Top Behav Neurosci 3: 3-27.
40. Korotkova TM, Eriksson KS, Haas HL, Brown RE, (2002) Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept 104: 83-89.
41. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE, (2003) Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 23: 7-11.
42. Borgland SL, Storm E, Bonci A, (2008) Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons. Eur J Neurosci 28: 1545-1556.
43. Margolis EB, Lock H, Hjelmstad GO, Fields HL, (2006) The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? J Physiol 577: 907-924.
44. Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, et al. (2000) Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats. Regul Pept 96: 71-84.
45. Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, et al. (2001) SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci 13: 1444-1452.
46. Borgland SL, Chang SJ, Bowers MS, Thompson JL, Vittoz N, et al. (2009) Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 29: 11215-11225.
47. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, et al. (2001) Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435: 6-25.
48. Balcita-Pedicino JJ, Sesack SR, (2007) Orexin axons in the rat ventral tegmental area synapse infrequently onto dopamine and gamma-aminobutyric acid neurons. J Comp Neurol 503: 668-684.
49. Novick A, Yaroslavsky I, Tejani-Butt S, (2008) Strain differences in the expression of dopamine D1 receptors in Wistar-Kyoto (WKY) and Wistar rats. Life Sci 83: 74-78.
50. Wanat MJ, Sparta DR, Hopf FW, Bowers MS, Melis M, et al. (2009) Strain specific synaptic modifications on ventral tegmental area dopamine neurons after ethanol exposure. Biol Psychiatry 65: 646-653.
51. Koob GF, Volkow ND, (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
52. Vittoz NM, Berridge CW, (2006) Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 31: 384-395.
53. Moorman DE, Aston-Jones G, (2010) Orexin/hypocretin modulates response of ventral tegmental dopamine neurons to prefrontal activation: diurnal influences. J Neurosci 30: 15585-15599.
54. James MH, Charnley JL, Levi EM, Jones E, Yeoh JW, et al. (2011) Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking. Int J Neuropsychopharmacol 14: 684-690.
55. Barson JR, Morganstern I, Leibowitz SF, (2011) Similarities in hypothalamic and mesocorticolimbic circuits regulating the overconsumption of food and alcohol. Physiol Behav 104: 128-137.
56. Cason AM, Smith RJ, Tahsili-Fahadan P, Moorman DE, Sartor GC, et al. (2010) Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav 100: 419-428.
57. Aston-Jones G, Smith RJ, Sartor GC, Moorman DE, Massi L, et al. (2010) Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction. Brain Res 1314: 74-90.
58. Zhu Y, Miwa Y, Yamanaka A, Yada T, Shibahara M, et al. (2003) Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and-insensitive G-proteins. J Pharmacol Sci 92: 259-266.
59. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, Guan XM, (1998) Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438: 71-75.
60. Kilduff TS, de Lecea L, (2001) Mapping of the mRNAs for the hypocretin/orexin and melanin-concentrating hormone receptors: networks of overlapping peptide systems. J Comp Neurol 435: 1-5.